Amedisys (NASDAQ:AMED) Releases Earnings Results, Misses Estimates By $0.09 EPS

Amedisys (NASDAQ:AMED) posted its earnings results on Wednesday. The health services provider reported $0.96 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09), Zacks reports. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $598.05 million during the quarter, compared to the consensus estimate of $602.38 million.

Amedisys Stock Performance

NASDAQ:AMED opened at $91.57 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The business has a fifty day simple moving average of $91.26 and a two-hundred day simple moving average of $93.25. Amedisys has a 1 year low of $82.15 and a 1 year high of $98.95. The company has a market capitalization of $3.00 billion, a P/E ratio of 36.34, a P/E/G ratio of 1.78 and a beta of 0.73.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an “equal weight” rating and set a $101.00 price target on shares of Amedisys in a research report on Wednesday, February 12th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.